Exclusive-Nippon Steel alleges undue White House influence on doomed deal review, letter says

By Alexandra Alper WASHINGTON (Reuters) -Nippon Steel alleges the White House had “impermissible undue influence” over a national security review of its $14.9 billion bid for U.S. Steel and threatened legal action if the deal is blocked. The accusation was made in a Dec. 17 letter, signed by counsel for Nippon Steel and U.S. Steel…

Read More

Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder. The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company…

Read More